ExeVir Announces Michael Garrett as New Chief Executive Officer
GHENT, Belgium, Nov. 18, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing heavy chain-only antibodies targeting highly conserved epitopes for broad protection against infectious diseases, announces the appointment of Michael Garrett as its …